A single-arm, open-label, phase 2 study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer (NSCLC)
Year: 2016
Type: article
Source: Annals of Oncology
Authors: M. Socinski, M. Gil, J. Shahidi, G.Y. Chao, L. Villaruz
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2589087095
